Our patients should be regarded as representative in their clinical (e.g., age, performance status, and survival), biological (e.g., tumor and cancer cell characteristics), and prognostic parameters (e.g., Leibovich score, tumor characteristics, and CRP level). This evidence concerns the gene CRP and cancer.